HOME >> BIOLOGY >> NEWS
Chemical derived from vitamin-E shows early promise as cancer drug

AUSTIN, Texas By studying cancer in mice, researchers at The University of Texas at Austin have gained preliminary evidence that a novel compound that resembles vitamin E halves the size of tumors and the ability of cancer to spread to other body sites.

"We have clear evidence that this chemical is directly causing cancer cells to die," said Kimberly Kline, a nutrition professor in the Department of Human Ecology who directed the research in collaboration with Bob G. Sanders, a professor in the School of Biological Sciences.

The findings will be published in the October issue of Experimental Biology and Medicine. They result from studies involving treatment of genetically identical mice, which were given the novel vitamin E compound either orally or by aerosol.

Based on earlier, similar findings by Kline and colleagues, the National Cancer Institute is funding national efforts to investigate the ability of this novel compound, RRR-alpha-tocopherol ether acetic analog (alpha-TEA), to prevent colon and breast cancers in preclinical animal models.

Mice in the study were treated with alpha-TEA for 21 days after an injection of mouse-derived mammary cancer cells that normally would have formed a tumor mass and spread (metastasized) to the animals' lungs. Regardless of whether alpha-TEA was administered to the mice by mouth (orally) or via breathing (aerosol), the compound was capable of reducing the primary tumor mass by greater than half.

In addition, the compound was capable of reducing tumor lesions (metastases) in the lung that were big enough to see with the naked eye. For example, only one of 10 alpha-TEA aerosol-treated mice developed visible lung tumor lesions in comparison to five of 10 untreated control mice. None of the treated animals showed any type of general symptoms of toxicity to alpha-TEA, which Kline chose for further study in 1997 from 50 candidates.

Because cancer may result from
'"/>

Contact: Barbra Rodriguez
brodriguez@mail.utexas.edu
512-232-0675
University of Texas at Austin
30-Sep-2004


Page: 1 2 3

Related biology news :

1. Chemical engineering grad students will take notable national awards
2. Chemical genetics identifies SARS inhibitors
3. Chemical signals health of brain cells Symposium
4. Highlights of American Chemical Society national meeting in Philadelphia, Aug. 22-26
5. Chemical engineers discover filtration system to help biotech industry
6. NIH roadmap for biomedical research focus of chemists at American Chemical Society meeting
7. American Chemical Society media registration
8. Chemical Society announces EPA awards for environmentally friendly technology
9. NIH launches first center in Nationwide Chemical Genomics Network
10. Chemical reaction in birds provides sense of direction during migratory flights
11. Annual Chemical Biology Symposium at Yale May 14, 2004

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/3/2020)... ... August 03, 2020 , ... ... a new partnership with medical equipment manufacturer, Spectrum Solutions, to provide COVID-19 saliva ... strengthen their laboratory supply chain for more than 10 years. Early in the ...
(Date:7/22/2020)... ... July 21, 2020 , ... ... in technology and compliance, announces a new solution to manage regulated workloads on ... layer of their technology stack complies with FDA and global regulations. USDM's new ...
(Date:7/10/2020)... ... July 08, 2020 , ... Overcoming Comparability Issues in Regenerative ... Webinar, Wednesday, July 22, 2020 • 1:30 p.m.-3:00 p.m. EDT, https://www.fdanews.com/cellandgenetherapy ... effective way to complete one? Will the study comply with all FDA requirements? ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... (PRWEB) , ... August 11, ... ... a biopharmaceutical cold chain validation engineering firm, is making available for free ... the need to incorporate concurrent transport simulation testing into today’s biologics licensing ...
(Date:8/7/2020)... ... August 06, 2020 , ... VGXI, a highly regarded ... on the purchase of greenfield for a new, expanded manufacturing facility. The site ... acres in the initial acquisition, with an option to purchase an additional 21 ...
(Date:8/3/2020)... ... ... Introducing Ardent Animal Health – MediVet Biologics rebrands company and positions its ... MediVet Biologics since its formation in 2016, the company is relaunching itself under the ... on its base of innovative therapies for osteoarthritis and cancer. , ...
(Date:7/31/2020)... ... 29, 2020 , ... G-CON Manufacturing, the leader in off-site ... FOR LIFE.” The adoption of this taglines comes at a time of tremendous ... to provide patients with urgently needed vaccines and other lifesaving pharmaceutical treatments. G-CON’s ...
Breaking Biology Technology:
Cached News: